Loading clinical trials...
Loading clinical trials...
The objective of the present registry is the creation of a prospective registry collecting clinico-pathological and genomic data, along with survival outcomes, of individuals diagnosed with PDAC at or...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Azienda Ospedaliera Universitaria Integrata Verona
NCT04900818 · Solid Tumor, Advanced Cancer, and more
NCT06922591 · PDAC, PDAC - Pancreatic Ductal Adenocarcinoma, and more
NCT07243262 · Pancreatic Cancer, PDAC - Pancreatic Ductal Adenocarcinoma
NCT05218889 · Pancreatic Cancer, PDAC - Pancreatic Ductal Adenocarcinoma, and more
NCT06625320 · Pancreatic Cancer, PDAC, and more
AOUI Verona
Verona
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions